Ethypharm

M. Hugues Lecat has been appointed Chairman and Chief Executive Officer of the Management Board of the pharmaceutical company Ethypharm.

Ethypharm and Meda have just spread their collaboration for the marketing of Axorid ® in Eastern Europe. This “once a day” formulation is the first fixed association of ketoprofen with omeprazole, developed by Ethypharm. The first agreement, signed in 2007, concerned Western and Central Europe.

October 2009, Paris – France : Ethypharm announce the launch, by Mundipharma, in France and in Germany of an Orodispersible form of Oxycodone marketed under the name of OxynormOro® and Oxynorm Dispersa®.

Ethypharm, a pharmaceutical technology based company, announced that United States Food and Drug Administration (FDA) recently completed two Inspections at its manufacturing facilities.